2025 American Academy of Neurology Abstract Website

Disclosures for "Endothelial Activation as a Predictor of Mortality in CD19-Directed CAR-T Therapy"

Mr. Cabrera Maqueda has nothing to disclose.
Dr. Fonseca has nothing to disclose.
Dr. Serra Smith has nothing to disclose.
Mrs. alaña has nothing to disclose.
Mr. Velilla-Alonso has nothing to disclose.
Dr. Hernandez-Chamorro has nothing to disclose.
Dr. Gil-Perotin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Gil-Perotin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Gil-Perotin has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Gil-Perotin has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Mrs. Martín-Aguilar has nothing to disclose.
Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Roser Velasco Fargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving as a Consultant for Seagen. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. The institution of Roser Velasco Fargas has received research support from ISCIII.
Mr. Chico-García has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Bristol-Myers Squib, Johnson&Johnson. The institution of Mr. Chico-García has received research support from Bristol-Myers Squib. Mr. Chico-García has received intellectual property interests from a discovery or technology relating to health care.
Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Angelini. Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for EISAI. Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Jazz Pharma. The institution of Dr. Cabezudo-García has received research support from Junta de Andalucía. Neuro-Reca.
Dr. Izquierdo has nothing to disclose.
Dr. CACABELOS has nothing to disclose.
Ines Gonzalez Suarez has nothing to disclose.
Mrs. Massot Cladera has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alter.
Jaime Gallego Perez De Lar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J.
Estefania Garcia Molina has nothing to disclose.
Mr. torres iglesias has nothing to disclose.
Miss Dominguez Gallego has nothing to disclose.
Miss Alcantara has nothing to disclose.
Mr. Guerra-Fernandez has nothing to disclose.
Mrs. Alba Isasi has nothing to disclose.
Miss Martinez Cibrian has nothing to disclose.
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Sanofi. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a speaker honoraria with Terumo. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Janssen. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
Dr. Blanco Morgado has nothing to disclose.